Nu-Med Plus (NUMD) Free Cash Flow (QoQ) (2012 - 2025)
Nu-Med Plus (NUMD) Free Cash Flow (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 176.64 Bn | 6.27 Bn |
| 2 | Stryker | 128.78 Bn | 125.90 Bn | 3.81 Bn |
| 3 | Medtronic | 109.01 Bn | 99.79 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn |
| 7 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -207.09% |
| Jun 30, 2024 | -414.44% |
| Mar 31, 2024 | 89.49% |
| Dec 31, 2023 | 77.31% |
| Sep 30, 2023 | 18.22% |
| Jun 30, 2023 | -14.41% |
| Mar 31, 2023 | 17.46% |
| Dec 31, 2022 | -3,990.61% |
| Sep 30, 2022 | 124.75% |
| Jun 30, 2022 | 79.10% |
| Mar 31, 2022 | 39.81% |
| Dec 31, 2021 | 50.81% |
| Sep 30, 2021 | 38.30% |
| Jun 30, 2021 | 16.16% |
| Mar 31, 2021 | -11.21% |
| Dec 31, 2020 | 29.47% |
| Sep 30, 2020 | 31.44% |
| Jun 30, 2020 | -54.78% |
| Mar 31, 2020 | 23.64% |
| Dec 31, 2019 | -65.20% |